Anxiety Disorders Completed Phase 4 Trials for Pregabalin (DB00230)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00706836PharmacofMRI of Anxiolytic Medications (Pregabalin)Diagnostic